Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Artificial Hip and Knee Joints Market Size & Growth Forecast 2027–2036, By Segments (Site, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12373| Published Date: Jun-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Artificial Hip and Knee Joints Market size was worth USD 13.56 billion in 2026 and is poised to grow at a 2.71% CAGR between 2027 and 2036, crossing USD 17.72 billion by 2036. The industry revenue for 2027 is assessed at USD 13.87 billion.

Base Year Value (2026)
USD 13.56 billion
CAGR (2027-2036)
2.71%
Forecast Year Value (2036)
USD 17.72 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Artificial Hip and Knee Joints Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads with 48.76% share due to high joint replacement volumes, advanced orthopedic care systems, and strong adoption of implant technologies across hospitals and specialty centers.
  • Asia Pacific is expanding at 3.31% CAGR, supported by improving surgical access, expanding hospital infrastructure, and rising adoption of joint replacement procedures in developing healthcare systems.

Segment Momentum

  • Knee Joints held a 60.14% share in 2026, supported by high replacement procedure volumes, established treatment pathways, and consistent implant utilization across routine orthopedic care.
  • Orthopedic Clinics are growing fastest as patients increasingly seek specialized musculoskeletal care, benefiting from focused expertise, streamlined referrals, and efficient follow-up within the joint replacement care pathway.

Market Expansion Drivers

  • Rising geriatric population and osteoarthritis prevalence driving demand for joint replacement procedures.
  • Advancements in minimally invasive orthopedic implants improving surgical outcomes and recovery times.
  • Increasing sports injuries and mobility disorders expanding orthopedic implant adoption across younger populations.

Leading Market Participants

  • Top companies in the artificial hip and knee joints market include Zimmer Biomet Holdings, Inc. (United States), Stryker Corporation (United States), Johnson & Johnson (United States), Smith & Nephew plc (United Kingdom), Exactech, Inc (United States), Enovis Corporation (United States), Medacta International SA (Switzerland), MicroPort Scientific Corporation (China), Corentec Co., Ltd. (South Korea).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 13.56 billion
  • 2027 Estimated Market Size: USD 13.87 billion.
  • Projected Market Size: USD 17.72 billion by 2036
  • Growth Forecast: 2.71% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Knee Joints (Site) | Hospitals & Surgery Centers (End Use)
  • Emerging Opportunity Segment: Hip Joints (Site) | Orthopedic Clinics (End Use)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising geriatric population and osteoarthritis prevalence driving demand for joint replacement procedures

The artificial hip and knee joints market is expanding as population aging and the increasing burden of degenerative joint conditions contribute to greater demand for joint replacement procedures. Osteoarthritis can progressively impair mobility, cause persistent pain, and restrict daily activities, particularly among older adults, creating a need for surgical intervention when conservative treatments no longer provide adequate relief. Hip and knee replacement procedures can restore joint function and improve mobility for appropriately selected patients, making them important treatment options for advanced joint degeneration. Improvements in implant design, surgical planning, fixation techniques, and postoperative rehabilitation are further supporting the use of replacement procedures among patients requiring durable mobility solutions.

Advancements in minimally invasive orthopedic implants improving surgical outcomes and recovery times

Technological advancements in implant design and minimally invasive orthopedic techniques are strengthening the artificial hip and knee joints market by enabling surgeons to pursue procedures with greater precision and reduced disruption to surrounding tissues. Modern implant systems increasingly incorporate designs intended to replicate natural joint movement, improve fixation, and accommodate different anatomical requirements. Minimally invasive approaches can also support smaller surgical access and more efficient postoperative recovery when clinically appropriate, while advanced planning technologies help surgeons select and position implants more accurately. These developments are encouraging greater interest in orthopedic replacement solutions as patients and healthcare providers place increasing emphasis on functional recovery and mobility following surgery.

Increasing sports injuries and mobility disorders expanding orthopedic implant adoption across younger populations

Growing incidence of sports-related injuries and mobility disorders is broadening the artificial hip and knee joints market beyond its traditional concentration among older patients. Severe joint damage, traumatic injuries, cartilage deterioration, and other mobility-limiting conditions can affect younger and physically active individuals, particularly when previous injuries contribute to progressive joint deterioration. For patients with substantial structural damage and persistent functional limitations, joint replacement may become an option after other treatments have been considered. Advances in implant materials, anatomical designs, fixation methods, and surgical techniques are also supporting the development of replacement solutions suited to varying activity levels and anatomical requirements.

Growth Drivers

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising geriatric population and osteoarthritis prevalence driving demand for joint replacement procedures 1.20% High North America, Europe High Near Term
Advancements in minimally invasive orthopedic implants improving surgical outcomes and recovery times 1.00% High North America, Asia Pacific High Mid Term
Increasing sports injuries and mobility disorders expanding orthopedic implant adoption across younger populations 0.90% Moderate North America, Europe Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Artificial Hip and Knee Joints Market
Largest Region
North America
48.76% Market Share in 2026

North America (Largest Region)

In the artificial hip and knee joints market, North America held the largest share of 48.76% in 2026, supported by advanced orthopedic healthcare infrastructure, established joint replacement practices, and broad access to specialized surgical care. The growing prevalence of age-related joint disorders and other musculoskeletal conditions is sustaining demand for hip and knee replacement procedures. Technological progress in implant design, materials, and surgical techniques is also improving treatment options and encouraging adoption. Strong clinical capabilities and emphasis on restoring mobility and quality of life further support the region's leading position.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, driven by population aging, increasing prevalence of joint-related disorders, and improving access to orthopedic healthcare. Expanding hospital infrastructure and greater availability of specialized surgical services are enabling more patients to undergo joint replacement procedures. Rising healthcare expenditure and growing awareness of advanced orthopedic treatments are further supporting demand for artificial joints. Increasing adoption of improved implant technologies and investments in modern surgical facilities are expected to broaden access and strengthen market development across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Rehabilitation-Oriented Demand

Germany emphasizes joint replacement solutions that support faster recovery and long-term mobility improvement. Demand in Germany increasingly centers on high-quality hip and knee implants that complement the country's established orthopedic rehabilitation and post-surgical care infrastructure.

France 🇫🇷

Mobility Restoration Priority

France maintains steady demand for artificial hip and knee joints through continued emphasis on managing age-related musculoskeletal conditions. Healthcare providers in France increasingly prioritize implant solutions that deliver reliable performance and support efficient postoperative recovery pathways.

Italy 🇮🇹

Elective Orthopedic Demand

Italy's market for artificial hip and knee joints is supported by sustained demand for elective orthopedic procedures among aging patient groups. Hospitals in Italy are increasingly seeking implant systems that balance long-term functionality with procedural efficiency and streamlined surgical workflows.

Japan 🇯🇵

Longevity-Driven Procedures

Japan's aging population continues to sustain demand for hip and knee replacement procedures aimed at preserving mobility and quality of life. The market in Japan increasingly favors durable implants and surgical approaches that minimize recovery burdens for elderly patients.

South Korea 🇰🇷

Premium Procedure Expansion

South Korea is seeing increased adoption of advanced joint replacement procedures supported by sophisticated hospital infrastructure and patient awareness. Demand in South Korea increasingly focuses on modern implant technologies and surgical techniques that enhance procedural precision and patient satisfaction.

United States 🇺🇸

Advanced Implant Adoption

The U.S. artificial hip and knee joints market is characterized by strong uptake of technologically advanced implants and increasing demand for personalized joint replacement solutions. Providers in the U.S. continue to expand the use of robotic-assisted procedures and implants designed to improve long-term outcomes.

Segment Analysis

Segment Leadership and Growth Trends

Artificial Hip and Knee Joints Market Share (%), by Site, 2026

Knee Joints
Hip Joints

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Site Segment Analysis: Knee Joints (Largest Segment) vs Hip Joints (Fastest-Growing Segment)

Knee joints dominated the artificial hip and knee joints market, accounting for a 60.14% share in 2026, supported by the substantial clinical burden associated with knee disorders and the widespread use of joint replacement procedures to restore mobility and reduce pain. Knee replacement is increasingly utilized for patients affected by degenerative joint conditions and mobility-limiting disorders, while improvements in implant design, surgical techniques, and postoperative rehabilitation continue to support procedure adoption. The growing focus on maintaining functional independence among aging populations also reinforces demand for durable and clinically effective knee joint replacement solutions.

Hip joints represent the fastest-growing site segment as demand increases for effective treatment of conditions that significantly impair mobility and quality of life. Advances in implant materials, component design, and minimally invasive surgical approaches are improving the functional outcomes associated with hip replacement procedures. Greater emphasis on earlier intervention and restoration of mobility is also encouraging the use of artificial hip joints among suitable patients. These developments are strengthening the role of hip replacement within orthopedic care and supporting faster expansion of the segment.

End Use Segment Analysis: Hospitals & Surgery Centers (Largest Segment) vs Orthopedic Clinics (Fastest-Growing Segment)

In the artificial hip and knee joints market, hospitals & surgery centers held the largest share of 67.61% in 2026, reflecting their extensive infrastructure for performing complex orthopedic procedures and managing patients throughout the surgical care pathway. These facilities provide access to specialized orthopedic surgeons, advanced operating environments, diagnostic capabilities, anesthesia services, and postoperative monitoring, making them well suited for joint replacement procedures. Their ability to coordinate multidisciplinary care and manage patients requiring more comprehensive support continues to sustain their leading position.

Orthopedic clinics are the fastest-growing end-use segment as the delivery of specialized musculoskeletal care increasingly shifts toward focused outpatient and ambulatory environments. These clinics provide patients with direct access to orthopedic specialists and can support streamlined evaluation, treatment planning, rehabilitation, and follow-up services. Growing interest in efficient care pathways and less resource-intensive procedures is creating greater opportunities for orthopedic clinics to participate in joint replacement-related care. Improvements in surgical techniques and recovery protocols are further supporting the expansion of specialized orthopedic treatment settings.

Segment Sub-Segment Largest Segment Fastest Growing
Site Hip Joints, Knee Joints Knee Joints Hip Joints
End Use Hospitals & Surgery Centers, Orthopedic Clinics, Others Hospitals & Surgery Centers Orthopedic Clinics
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the artificial hip and knee joints market:

1. Zimmer Biomet Holdings Inc. (United States)

2. Stryker Corporation (United States)

3. Johnson & Johnson (United States)

4. Smith & Nephew plc (United Kingdom)

5. Exactech Inc (United States)

6. Enovis Corporation (United States)

7. Medacta International SA (Switzerland)

8. MicroPort Scientific Corporation (China)

9. Corentec Co. Ltd. (South Korea)

Rising patient expectations for mobility restoration are fueling advancements in joint replacement technologies. Material enhancements are improving implant durability and biocompatibility outcomes. The artificial hip and knee joints market is progressing with a focus on long-term functional performance improvements.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Zimmer Biomet Holdings Inc. (United States)
Stryker Corporation (United States)
Johnson & Johnson (United States)
Smith & Nephew plc (United Kingdom)
Exactech Inc (United States)
Enovis Corporation (United States)
Medacta International SA (Switzerland)
MicroPort Scientific Corporation (China)
Corentec Co. Ltd. (South Korea).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Corentec Feb-24 Corentec received U.S. FDA clearance for the BENCOX Mirabo Z Cup Continuum hip implant component. The approval enables commercialization of the artificial hip cup in the U.S. market, strengthening Corentec’s presence in orthopedic implant systems and expanding its product offering in hip reconstruction solutions.
Medacta Group S.A. Oct-23 Medacta Group S.A. introduced the GMK SpheriKA femoral component designed for kinematic alignment in total knee replacement procedures. The product enhances surgical precision in knee arthroplasty by supporting alignment-specific implantation strategies aimed at improving procedural outcomes in joint reconstruction.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Artificial Hip and Knee Joints Market — Custom Segments

Segment Sub-Segment
Fixation Method Cemented Fixation, Cementless Fixation, Hybrid Fixation
Bearing Surface Metal-on-Polyethylene, Ceramic-on-Polyethylene, Ceramic-on-Ceramic, Metal-on-Metal
Implant Design Fixed-Bearing Designs, Mobile-Bearing Designs, Conventional Designs, Highly Constrained Designs

Artificial Hip and Knee Joints Market — Custom TOC

Custom Chapter Custom Details
Implant Lifecycle Management Analysis
  • Implant Selection and Initial Procedure
  • Postoperative Monitoring and Follow-Up
  • Implant Longevity and Performance Management
  • Revision Triggers and Lifecycle Challenges
  • Lifecycle Optimization Opportunities
Revision Surgery Market Opportunity Analysis
  • Revision Procedure Demand Drivers
  • Implant Failure and Complication Patterns
  • Patient and Procedure Characteristics
  • Revision Technology and Implant Requirements
  • Market Opportunity Priorities
Orthopedic Implant Innovation Pathway Assessment
  • Implant Design and Material Innovation
  • Digital and Patient-Specific Technologies
  • Surgical Technique Advancements
  • Innovation Adoption Considerations
  • Emerging Implant Development Priorities
  • Commercialization Pathways

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the market valuation of artificial hip and knee joints?

The market size of the artificial hip and knee joints is estimated at USD 13.87 billion in 2027.

What are the growth projections for the artificial hip and knee joints industry?

Artificial Hip and Knee Joints Market size was worth USD 13.56 billion in 2026 and is poised to grow at a 2.71% CAGR between 2027 and 2036, crossing USD 17.72 billion by 2036.

How are demographic and disease trends driving demand in the artificial hip and knee joints market?

An expanding elderly population and increasing osteoarthritis prevalence are raising joint replacement procedure volumes as providers and patients increasingly rely on implant-based treatment to restore mobility and daily function.

How are advances in implant design expanding adoption in the artificial hip and knee joints market?

Minimally invasive implant innovations improve recovery, reduce tissue disruption, and enhance surgical efficiency, encouraging broader hospital adoption and supporting earlier intervention for patients requiring joint replacement.

Why do Knee Joints account for the largest share of the artificial hip and knee joints market?

Knee Joints held a 60.14% share in 2026, supported by high replacement procedure volumes, established treatment pathways, and consistent implant utilization across routine orthopedic care.

Why are Orthopedic Clinics the fastest-growing end-use segment in the artificial hip and knee joints market?

Orthopedic Clinics are growing fastest as patients increasingly seek specialized musculoskeletal care, benefiting from focused expertise, streamlined referrals, and efficient follow-up within the joint replacement care pathway.

Why is North America the largest market for artificial hip and knee joints?

North America leads with 48.76% share due to high joint replacement volumes, advanced orthopedic care systems, and strong adoption of implant technologies across hospitals and specialty centers.

What is driving Asia Pacific growth in artificial hip and knee joints?

Asia Pacific is expanding at 3.31% CAGR, supported by improving surgical access, expanding hospital infrastructure, and rising adoption of joint replacement procedures in developing healthcare systems.

Which companies dominate the artificial hip and knee joints landscape?

Top companies in the artificial hip and knee joints market include Zimmer Biomet Holdings, Inc. (United States), Stryker Corporation (United States), Johnson & Johnson (United States), Smith & Nephew plc (United Kingdom), Exactech, Inc (United States), Enovis Corporation (United States), Medacta International SA (Switzerland), MicroPort Scientific Corporation (China), Corentec Co., Ltd. (South Korea).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →